Showing results (51-60 of 122) with videos related to
Sort By:
Pageof 13
Journal of Pharmaceutical Sciences|October 1, 1990
Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivoE J van Hoogdalem, C Vermeij-Kerrs, A G de Boer, et al.Mycoses|November 8, 2002
High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilitiesT Matos, G S de Hoog, A G de Boer, et al.Pharmacology|January 1, 1979
Assay of 3-carboxy-antipyrine in urine by capillary gas chromatography with nitrogen selective detection. Some preliminary results in manM Danhof, A G de Boer, E de Groot-van der Vis, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measuresJ W Mandema, C D Heijligers-Feijen, E Tukker, et al.Peptides|January 1, 1992
In vitro penetration of des-tyrosine1-D-phenylalanine3-beta-casomorphin across the blood-brain barrierH Stark, J B Van Bree, A G de Boer, et al.Brain Research|December 8, 1995
Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeabilityE C de Lange, M Danhof, C Zurcher, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1982
Zero-order rectal delivery of theophylline in man with an osmotic systemL G de Leede, A G de Boer, S L van Velzen, et al.Clinical Pharmacology and Therapeutics|December 1, 1979
Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolismA G de Boer, D D Breimer, H Mattie, et al.Neuroreport|July 12, 2001
Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosisP J Gaillard, P H van Der Meide, A G de Boer, et al.Archives Internationales De Pharmacodynamie Et De Therapie|February 1, 1981
Pharmacokinetics of etomidate in surgical patientsG de Ruiter, D T Popescu, A G de Boer, et al.Pageof 13